The Angiography Characteristic of Free Wall Ruptrue in STEMI

December 28, 2019 updated by: Bin Wang, Xiamen Cardiovascular Hospital, Xiamen University

The Coronary Angiography Characteristic of Free Wall Ruptrue in ST-Elevation Myocardial Infarction Patients

To analyze whether the location of myocardial infarction and infarct related artery are related to FWR.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

To know the characteristic of FWR that different location of STEMI and coronary distribution

Study Type

Observational

Enrollment (Anticipated)

14629

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Fujian
      • Xiamen, Fujian, China, 361000
        • Recruiting
        • Xiamen Cardiovascular Hospital Xiamen University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

STEMI patients anticipated to undergo angiography

Description

Inclusion Criteria:

  1. Patients had to be ≥18 years of age, be admitted for STEMI
  2. Accord with STEMI diagnostic criteria
  3. STEMI patients anticipated to undergo angiography

Exclusion Criteria:

  1. Pregnant
  2. Acute stroke
  3. Aortic dissection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Anterior infarction
Patients with anterior ST-elevation myocardial infarction
Diagnostic test: Coronary intervention
Patients with STEMI undergo coronary intervention
Inferior infarction
Patients with inferior ST-elevation myocardial infarction
Diagnostic test: Coronary intervention
Patients with STEMI undergo coronary intervention
Lateral infarction
Patients with lateral ST-elevation myocardial infarction
Diagnostic test: Coronary intervention
Patients with STEMI undergo coronary intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of cardiac death
Time Frame: 30 days
In-hospital cardiac death during 30 days
30 days
Number of free-wall rupture
Time Frame: 30 days
The FWR after STEMI patients
30 days
Number of reperfusion arrhythmia
Time Frame: 30 days
Reperfusion arrhythmia during coronary intervention
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FMC time
Time Frame: 30 days
First Medical Contact time
30 days
Symptom onset to angiology time
Time Frame: 30 days
The time from symptom onset to beginning of angiography
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Xiamen Cardiovascular Hospital, Xiamen University

Investigators

  • Study Director: Bin Wang, PhD, Xiamen Cardiovascular Hospital, Xiamen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2011

Primary Completion (Anticipated)

August 31, 2020

Study Completion (Anticipated)

September 30, 2020

Study Registration Dates

First Submitted

December 25, 2019

First Submitted That Met QC Criteria

December 26, 2019

First Posted (Actual)

December 30, 2019

Study Record Updates

Last Update Posted (Actual)

January 2, 2020

Last Update Submitted That Met QC Criteria

December 28, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 9215443693

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe